Jones Financial Companies Lllp raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 55.0% during the 4th quarter, ...

Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also significantly ...

Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch and urticaria activity with dupilumab, according to a poster presented here.

Recent refinements to a multiphase approach to delusional infestations make this treatment protocol effective even within a ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

Matthew Bedrossian is general counsel at Evidation - a company that measures health in everyday life and enables anyone to ...

Key Innovations and 5 Companies to Watch in 2025Artificial intelligence is everywhere in 2024, changing industries and ...

The global back therapy kit market, valued at USD 4 billion in 2024, is poised for significant growth, projected to reach USD 6.1 billion by 2034, according to industry reports. This expansion is ...

B. Riley cut their Q1 2025 earnings per share estimates for Novavax in a report issued on Monday, March 3rd. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will post ...

Such sponsorship deals were unheard of just four years ago. In 2021, California enacted a law allowing athletes to make these ...